Acadia Healthcare Company Inc. (ACHC) shares have surpassed the average analyst 12-month target price of $18.71, trading at $20.84 per share as of recent trading. This movement prompts analysts to reassess their positions, with some potentially raising their target prices and others considering downgrades based on valuation.
Among the 14 analysts covering ACHC, targets range from a low of $13.00 to a high of $25.00, resulting in a standard deviation of $4.232. The current breakdown of analyst ratings includes 5 “Strong Buy,” 2 “Buy,” 6 “Hold,” 1 “Sell,” and 1 “Strong Sell,” reflecting an average rating of 2.4—where 1 is a Strong Buy and 5 is a Strong Sell.
